Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$23.0 - $29.01 $4.37 Million - $5.52 Million
-190,200 Reduced 83.27%
38,200 $1.06 Million
Q2 2021

Aug 12, 2021

SELL
$27.43 - $32.7 $11.5 Million - $13.7 Million
-419,800 Reduced 64.76%
228,400 $6.7 Million
Q1 2021

May 17, 2021

BUY
$21.37 - $34.38 $2.32 Million - $3.73 Million
108,400 Added 20.08%
648,200 $20.6 Million
Q4 2020

Feb 12, 2021

BUY
$15.31 - $21.12 $8.26 Million - $11.4 Million
539,800 New
539,800 $11.2 Million
Q3 2020

Nov 13, 2020

SELL
$14.88 - $20.13 $3.48 Million - $4.7 Million
-233,600 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$13.31 - $20.51 $11.6 Million - $17.9 Million
-873,700 Reduced 78.9%
233,600 $4.27 Million
Q1 2020

May 13, 2020

SELL
$12.98 - $30.25 $2.76 Million - $6.44 Million
-213,000 Reduced 16.13%
1,107,300 $17.2 Million
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $12.9 Million - $21.7 Million
681,800 Added 106.78%
1,320,300 $39.5 Million
Q3 2019

Nov 12, 2019

BUY
$20.88 - $25.66 $7.41 Million - $9.11 Million
355,100 Added 125.3%
638,500 $14 Million
Q2 2019

Aug 12, 2019

SELL
$20.52 - $26.45 $8 Million - $10.3 Million
-389,700 Reduced 57.9%
283,400 $7.15 Million
Q1 2019

May 10, 2019

BUY
$20.23 - $26.29 $44,506 - $57,838
2,200 Added 0.33%
673,100 $16.6 Million
Q4 2018

Feb 13, 2019

BUY
$17.64 - $28.32 $3.48 Million - $5.59 Million
197,500 Added 41.72%
670,900 $12.4 Million
Q3 2018

Nov 09, 2018

BUY
$20.64 - $25.67 $9.77 Million - $12.2 Million
473,400 New
473,400 $12.2 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.88B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.